Posted on 31 December 2013.
Our lawyer of the week is Fidelma Fitzpatrick of the law firm of Motley Rice. Fidelma with her excellent team of lawyers and staff won one of the most important cases impacting the public ever litigated. As a result of her hard and tenacious work, Three companies have been ordered by a California judge to pay […]
Read the full story
Posted in Lawyer of the Week
Posted on 18 December 2013.
Scott Frost of Waters & Krause is our lawyer of the week for his tenacious work representing the family of Bill Saller who passed away from mesothelioma. When you think of a lawyer who never gives up you think of Scott . The case of Mr. Saller was first tried back in 2007. The jury […]
Read the full story
Posted in Lawyer of the Week
Posted on 10 December 2013.
Bloomberg News (12/6, Fisk, Calkins, 1.91M) reported that U.S. District Judge Keith P. Ellison rejected a class certification for investors seeking to sue BP over loss in the value of BP stock due to the Deepwater Horizon oil spill in 2010. “Ellison ruled that the investors failed to show that their damages could be calculated on […]
Read the full story
Posted in Legal News
Posted on 15 November 2013.
The Arkansas Democrat Gazette (11/9, Lynch) reports that a Pulaski County Circuit judge gave class-action status Friday to a deceptive-trade practices lawsuit against Philip Morris – now Altria – for its Malboro Lights, and that could create a plaintiff pool of some million or more people in Arkansas who bought Marlboro Lights or Ultra Lights beginning in 1971. Plaintiffs […]
Read the full story
Posted in Legal News, Product Safety
Posted on 11 November 2013.
As a result of the Mensing case the legal rights of more than 80 % of America’s population was placed at risk. If you are injured as a result of taking a generic drug, you have no legal rights for the failure to warn of the dangers known to be associated with that drug . […]
Read the full story
Posted in Cases that Change America, Legal News
Posted on 08 November 2013.
On its Tuesday broadcast, the CBS Evening News reported on former Ranbaxy executive Dinesh Thakur, who “was asked by his boss to investigate allegations of fraud at the company” in 2004. He soon “uncovered disturbing problems with the data required by the FDA to prove the effectiveness of Ranbaxy drugs.” According to Thakur, the company had “gotten approvals from […]
Read the full story
Posted in Legal News